Atsushi Nemoto to Antineoplastic Agents
This is a "connection" page, showing publications Atsushi Nemoto has written about Antineoplastic Agents.
Connection Strength
0.455
-
Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome-Positive Lymphoid Leukemia. Mol Cancer Ther. 2016 Jan; 15(1):94-105.
Score: 0.217
-
Diverse underlying proliferation response to growth factors in imatinib-treated Philadelphia chromosome-positive leukemias. Leuk Res. 2013 Jan; 37(1):93-101.
Score: 0.175
-
Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines. PLoS One. 2017; 12(12):e0188680.
Score: 0.062